CRISPR/Cas9 technology generated an arginine to glutamine substitution at amino acid 232 (p.R232Q). R232Q is a rare missense variant identified in two brothers afflicted with a progressive neuropathy syndrome. (J:335315)
查看原文 参与反馈
CRISPR/Cas9 technology generated an arginine to glutamine substitution at amino acid 232 (p.R232Q). R232Q is a rare missense variant identified in two brothers afflicted with a progressive neuropathy syndrome. (J:335315)